Treatment for very high blood fats (triglycerides)
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests an investigational medication called DR10624 for people with very high triglycerides, a type of fat in the blood that can increase the risk of heart problems and pancreatitis. The trial aims to see if this drug can safely lower triglycerides better than standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- Your body mass index (BMI) should be between 19 and 45, and you should weigh at least 110 pounds (50 kg).
- You need to have very high triglycerides, confirmed by blood tests taken more than a week apart.
- You must be on a stable cholesterol or triglyceride-lowering medication for at least 4 weeks.
- You should not have had recent pancreatitis, severe heart or kidney problems, or certain genetic conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This study tests a new drug (DR10624) to see if it helps lower high blood fats (triglycerides) and improve kidney health in people who have both type 2 diabetes and diabetic kidney disease. If you qualify, you may receive the study drug as part of the trial.
This trial tests a new drug, DR10624, to see if it can lower high triglycerides and reduce plaque in the carotid artery (the main artery in your neck). It may help people with both conditions who are also overweight.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This trial tests a new one-time gene-editing treatment (CS-121) for people with very high triglycerides that don't lower enough with standard medicines. The treatment aims to reduce triglycerides and could help prevent pancreatitis and heart problems, but it is an early-stage gene therapy with strict safety requirements.
This trial tests a medication (a GLP-1 agonist) to see if it can prevent another pancreatitis attack caused by very high triglycerides. If you recently had such an attack, this treatment might lower your risk of it happening again.
Hear when a new Severe Hypertriglyceridemia (sHTG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.